Bio-Techne Corp
NASDAQ:TECH

  • LAST PRICE
    74.4100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    58.7000/ 1
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 74.4100
  • Day Range
    ---
  • 52 Week Range
    56.4500
    85.5700
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
TECH
Bio-Techne Corp
11.8B
79.1x
+11.13%
SRPT
Sarepta Therapeutics Inc
10.9B
94.0x
---
TEM
Tempus AI Inc
10.7B
-8.2x
---
MEDP
Medpace Holdings Inc
11.2B
31.6x
+35.10%
NBIX
Neurocrine Biosciences Inc
12.9B
34.0x
+62.04%
EXEL
Exelixis Inc
10.2B
22.8x
-21.77%
As of 2024-11-13

Company Information

Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are specifically tailored to G-Rex Bioreactors. Its segments include Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, and tissue biopsy analysis.

Contact Information

Headquarters
614 MCKINLEY PL N EMINNEAPOLIS, MN, United States 55413
Phone
612-379-8854
Fax
612-656-4400

Executives

Independent Chairman of the Board
Robert Baumgartner
President, Chief Executive Officer, Chief Operating Officer, Director
Kim Kelderman
Chief Financial Officer, Executive Vice President - Finance
James Hippel
President - Protein Sciences
William Geist
President - Diagnostics and Genomics Segment
Matthew Mcmanus

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$11.8B
Revenue (TTM)
$1.2B
Shares Outstanding
158.9M
Dividend Yield
0.43%
Annual Dividend Rate
0.3200 USD
Ex-Dividend Date
11-08-24
Pay Date
11-22-24
Beta
1.27
EPS
$0.94
Book Value
$13.08
P/E Ratio
79.1x
Price/Sales (TTM)
10.1
Price/Cash Flow (TTM)
45.1x
Operating Margin
16.29%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.